Roles of microRNA in the regulation of tumor-associated macrophage polarization during the remodeling of breast cancer immune microenvironment

Abstract

Zhou Jiamin, Ye Lisha, Wang Guohua. Roles of microRNA in the regulation of tumor-associated macrophage polarization during the remodeling of breast cancer immune microenvironment[J]. Journal of International Oncology, 2020, 47(7): 428-430.

References20

[1]	郑新宇, 王秋丽. 2015年欧洲肿瘤内科学会《原发性乳腺癌诊断、治疗及随访指南》解读[J]. 中国实用外科杂志, 2016,36(7):763-770. DOI: 10.7504/CJPS.ISSN1005-2208.2016.07.14.
[2]	Ward EM, Desantis CE, Lin CC, et al. Cancer statistics: breast cancer in situ[J]. CA Cancer J Clin, 2015,65(6):481-495. DOI: 10.3322/caac.21321. doi:10.3322/caac.21321pmid:26431342
[3]	Li K, Wei L, Huang Y, et al. Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion[J]. Int J Oncol, 2016,48(6):2479-2487. DOI: 10.3892/ijo.2016.3483. doi:10.3892/ijo.2016.3483pmid:27082857
[4]	Kasahara VA, do Carmo Nicoletti M. Graph-based clustering of miRNA sequences[J]. Microrna, 2017,6(3):166-186. DOI: 10.2174/2211536606666170724154752. doi:10.2174/2211536606666170724154752pmid:28738776
[5]	Roy S. miRNA in macrophage development and function[J]. Antioxid Redox Signal, 2016,25(15):795-804. DOI: 10.1089/ars.2016.6728. doi:10.1089/ars.2016.6728pmid:27353423
[6]	Ngambenjawong C, Gustafson HH, Pun SH. Progress in tumor-associated macrophage (TAM)-targeted therapeutics[J]. Adv Drug Deliv Rev, 2017,114:206-221. DOI: 10.1016/j.addr.2017.04.010. pmid:28449873
[7]	李悦, 高磊, 李红昌, 等. M2型巨噬细胞标志物CD206与肿瘤[J]. 国际肿瘤学杂志, 2019,46(3):174-177. DOI: 10.3760/cma.j.issn.1673-422X.2019.03.009.
[8]	Falleni M, Savi F, Tosi D, et al. M1 and M2 macrophages' clinicopathological significance in cutaneous melanoma[J]. Melanoma Res, 2017,27(3):200-210. DOI: 10.1097/CMR.0000000000000352. pmid:28272106
[9]	Bednarczyk RB, Tuli NY, Hanly EK, et al. Macrophage inflam-matory factors promote epithelial-mesenchymal transition in breast cancer[J]. Oncotarget, 2018,9(36):24272-24282. DOI: 10.18632/oncotarget.24917. doi:10.18632/oncotarget.24917pmid:29849939
[10]	Mu X, Shi W, Xu Y, et al. Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer[J]. Cell Cycle, 2018,17(4):428-438. DOI: 10.1080/15384101.2018.1444305. pmid:29468929
[11]	Grossman JG, Nywening TM, Belt BA, et al. Recruitment of CCR2⁺tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer [J]. Oncoimmunology, 2018,7(9):e1470729. DOI: 10.1080/2162402X.2018.1470729. pmid:30228938
[12]	Ghoochani A, Schwarz MA, Yakubov E, et al. MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis[J]. Oncogene, 2016,35(48):6246-6261. DOI: 10.1038/onc.2016.160. pmid:27157615
[13]	Cui M, Yao X, Li Y, et al. Interactive functions of microRNAs in the miR-23a-27a-24-2 cluster and the potential for targeted therapy in cancer[J]. J Cell Physiol, 2020,235(1):6-16. DOI: 10.1002/jcp.28958. doi:10.1002/jcp.28958pmid:31192453
[14]	Ma S, Liu M, Xu Z, et al. A double feedback loop mediated by microRNA-23a/27a/24-2 regulates M1 versus M2 macrophage polarization and thus regulates cancer progression[J]. Oncotarget, 2016,7(12):13502-13519. DOI: 10.18632/oncotarget.6284. doi:10.18632/oncotarget.6284pmid:26540574
[15]	Zhong Y, Yi C. MicroRNA-720 suppresses M2 macrophage polari-zation by targeting GATA3[J]. Biosci Rep, 2016,36(4):e00363. DOI: 10.1042/BSR20160105. pmid:27354564
[16]	Weng YS, Tseng HY, Chen YA, et al. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer[J]. Mol Cancer, 2019,18(1):42. DOI: 10.1186/s12943-019-0988-0. doi:10.1186/s12943-019-0988-0pmid:30885232
[17]	Jia X, Li X, Shen Y, et al. MiR-16 regulates mouse peritoneal macrophage polarization and affects T-cell activation[J]. J Cell Mol Med, 2016,20(10):1898-1907. DOI: 10.1111/jcmm.12882. doi:10.1111/jcmm.12882pmid:27241533
[18]	Wang W, Liu Y, Guo J, et al. miR-100 maintains phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis via Stat5a/IL-1ra pathway in mouse breast cancer[J]. Oncogenesis, 2018,7(12):97. DOI: 10.1038/s41389-018-0106-y. doi:10.1038/s41389-018-0106-ypmid:30563983
[19]	Li Y, Zhao L, Shi B, et al. Functions of miR-146a and miR-222 in tumor-associated macrophages in breast cancer[J]. Sci Rep, 2015,5:18648. DOI: 10.1038/srep18648. pmid:26689540
[20]	Frank AC, Ebersberger S, Fink AF, et al. Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype[J]. Nat Commun, 2019,10(1):1135. DOI: 10.1038/s41467-019-08989-2. doi:10.1038/s41467-019-08989-2pmid:30850595

Roles of microRNA in the regulation of tumor-associated macrophage polarization during the remodeling of breast cancer immune microenvironment

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References20

Related Articles15

Recommended Articles

Metrics

Comments

[1]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[2]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.
[3]	Sa Qiang, Xu Hangcheng, Wang Jiayu.Advances in immunotherapy for breast cancer[J]. Journal of International Oncology, 2024, 51(4): 227-234.
[4]	Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer[J]. Journal of International Oncology, 2024, 51(4): 235-238.
[5]	Gong Yan, Chen Honglei.Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer[J]. Journal of International Oncology, 2024, 51(3): 186-190.
[6]	Chen Boguang, Wang Sugui, Zhang Yongjie.Role of serum cholinesterase and inflammatory markers in the prognosis of stage ⅠA -ⅢA breast cancer[J]. Journal of International Oncology, 2024, 51(2): 73-82.
[7]	Liu Xiaodi, Su Jianfei, Zhang Jingxian, Wei Xueqin, Jia Yingjie.Research progress of myeloid-derived suppressor cells in tumor angiogenesis[J]. Journal of International Oncology, 2024, 51(1): 50-54.
[8]	Gu Huayan, Zhu Teng, Guo Guilong.Breast microbiota and breast cancer： present and future[J]. Journal of International Oncology, 2024, 51(1): 55-58.
[9]	Wang Jing, Xu Wenting.Value of NLR， CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm[J]. Journal of International Oncology, 2023, 50(9): 520-526.
[10]	Feng Chengtian, Huang Furong, Cao Shiyu, Wang Jianyu, Nanding Abiyasi, Jiang Yongdong, Zhu Juanying.Relationships between HER2 protein expression and imaging features in HER2 positive breast cancer patients[J]. Journal of International Oncology, 2023, 50(9): 527-531.
[11]	Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng.Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway[J]. Journal of International Oncology, 2023, 50(8): 449-456.
[12]	Pan Shulan, Liu Chang, He Ping.Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer[J]. Journal of International Oncology, 2023, 50(8): 457-462.
[13]	Wang Wende, Zeng De.Research progress on the mechanism of endocrine therapy resistance for breast cancer[J]. Journal of International Oncology, 2023, 50(6): 352-356.
[14]	Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.Research progress on the application of combining radiotherapy and systemic therapy in breast cancer[J]. Journal of International Oncology, 2023, 50(6): 362-367.
[15]	Zhang Li, Xiang Zhuo, Wang Qiang, Bi Jingwang.Research progress of cytokine release syndrome related to CAR-T immunotherapy[J]. Journal of International Oncology, 2023, 50(6): 377-381.